Published in Lab Business Week, October 9th, 2005
According to recent research from Germany, "The proteolysis-inducing factor (PIF) was identified as a tumor product in various gastrointestinal cancers. A previous study in pancreatic cancer patients suggested PIF expression as a tumor marker, which is not related to tumor size."
"We hypothesized that PIF could be a useful marker to exclude benign pancreatic tumors, as chronic pancreatitis with a pancreatic mass. Urine of patients with a pancreatic mass of uncertain malignancy was investigated for PIF expression by Western blot," explained N....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week